These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25865925)

  • 21. Microneedling: a new approach for treating textural abnormalities and scars.
    Hogan S; Velez MW; Ibrahim O
    Semin Cutan Med Surg; 2017 Dec; 36(4):155-163. PubMed ID: 29224032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microneedling: Where do we stand now? A systematic review of the literature.
    Ramaut L; Hoeksema H; Pirayesh A; Stillaert F; Monstrey S
    J Plast Reconstr Aesthet Surg; 2018 Jan; 71(1):1-14. PubMed ID: 28690124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microneedles: an emerging transdermal drug delivery system.
    Bariya SH; Gohel MC; Mehta TA; Sharma OP
    J Pharm Pharmacol; 2012 Jan; 64(1):11-29. PubMed ID: 22150668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of hydrophobic peptides for skin delivery via coated microneedles.
    Zhao X; Coulman SA; Hanna SJ; Wong FS; Dayan CM; Birchall JC
    J Control Release; 2017 Nov; 265():2-13. PubMed ID: 28286315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations.
    Caffarel-Salvador E; Tuan-Mahmood TM; McElnay JC; McCarthy HO; Mooney K; Woolfson AD; Donnelly RF
    Int J Pharm; 2015 Jul; 489(1-2):158-69. PubMed ID: 25940042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety.
    Donnelly RF; Raj Singh TR; Woolfson AD
    Drug Deliv; 2010 May; 17(4):187-207. PubMed ID: 20297904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug Delivery Systems based on Microneedles for Dermatological Diseases and Aesthetic Enhancement.
    Vergilio MM; Birchall JC; Lima LL; Rezende RA; Leonardi GR
    Curr Med Chem; 2024; 31(23):3473-3487. PubMed ID: 37231729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microneedle Mediated Transdermal Delivery of Protein, Peptide and Antibody Based Therapeutics: Current Status and Future Considerations.
    Kirkby M; Hutton ARJ; Donnelly RF
    Pharm Res; 2020 Jun; 37(6):117. PubMed ID: 32488611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.
    Rejinold NS; Shin JH; Seok HY; Kim YC
    Expert Opin Drug Deliv; 2016; 13(1):109-31. PubMed ID: 26559052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micro-Needling Depth Penetration, Presence of Pigment Particles, and Fluorescein-Stained Platelets: Clinical Usage for Aesthetic Concerns.
    Sasaki GH
    Aesthet Surg J; 2017 Jan; 37(1):71-83. PubMed ID: 27530764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microneedles: bench to bedside.
    Kolli CS
    Ther Deliv; 2015; 6(9):1081-8. PubMed ID: 26419290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation and characterisation of dissolving microneedles for the transdermal delivery of therapeutic peptides.
    Dillon C; Hughes H; O'Reilly NJ; McLoughlin P
    Int J Pharm; 2017 Jun; 526(1-2):125-136. PubMed ID: 28461268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin.
    Ghosh P; Brogden NK; Stinchcomb AL
    J Pharm Sci; 2014 Feb; 103(2):652-60. PubMed ID: 24395718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delivery of large molecular protein using flat and short microneedles prepared using focused ion beam (FIB) as a skin ablation tool.
    Cheung K; West G; Das DB
    Drug Deliv Transl Res; 2015 Aug; 5(4):462-7. PubMed ID: 26227622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
    Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
    Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein.
    Oh JH; Park HH; Do KY; Han M; Hyun DH; Kim CG; Kim CH; Lee SS; Hwang SJ; Shin SC; Cho CW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1040-5. PubMed ID: 18411045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method of microneedle array fabrication for transdermal drug delivery.
    Kochhar JS; Goh WJ; Chan SY; Kang L
    Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward Biofunctional Microneedles for Stimulus Responsive Drug Delivery.
    Cahill EM; O'Cearbhaill ED
    Bioconjug Chem; 2015 Jul; 26(7):1289-96. PubMed ID: 26020359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biorejuvenation: theory and practice.
    Iorizzo M; De Padova MP; Tosti A
    Clin Dermatol; 2008; 26(2):177-81. PubMed ID: 18472058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microneedles for transdermal drug delivery.
    Prausnitz MR
    Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.